Material and Method: The data of 208 patients, who underwent radical prostatectomy between 2012-2018, were retrospectively analyzed. The surgical margin status of 147 pathologically organ-confined patients was categorized as positive, close (<1mm) and negative. Surgical margin status and parameters affecting biochemical recurrence were examined. Furthermore, multivariate analysis was done to determine the parameters associated with biochemical recurrence.
Results: Biochemical recurrence was detected in 21 (14.2%) of 147 patients. 38 (27.9%) men had negative surgical margins, 68 (46.2%) had close surgical margins and 41 (25.9%) had positive surgical margins. Tumor volume and ISUP grade were found to be statistically significant for positive surgical margin and close surgical margin patients compared to negative surgical margin patients. Close surgical margin was not statistically associated with biochemical recurrence. Preoperative high PSA (p<0.001) and positive surgical margin (p=0.021) were independent risk factors for biochemical recurrence.
Conclusion: According to our results, it is not necessary to include the presence of a close surgical margin in the pathology reports in patients with pathological organ-confined tumors and negative surgical margins.
On the other hand, BCR in cases with localized prostate carcinoma, where the positive surgical margin is not observed, suggests that not only the tumors contact with the surgical margin but also its proximity may affect the development of recurrence [4-7].
Although positive surgical margin rates decrease with developing surgical techniques, radical prostatectomy operations performed to maintain urinary and sexual function generally cause the prostate to be removed with surgical margins close to the tumor.
Even if the tumor is too close to an inked surface, the surgical margin is considered negative if it does not come into contact with the ink. However, the definition of surgical margin proximity for prostate cancer is not yet clear. In some cancers, the tumors proximity to the surgical margin has been shown to be correlated with the risk of recurrence. For example, in colon carcinoma, it has been stated that tumors close to the radial surgical margin and tumors that contact with the surgical margin have a similar rate of local and distant recurrence [8,9]. In prostate cancer, the cut-off values taken for the definition of the tumors proximity to the surgical margin vary and the effect of this factor on biochemical recurrence remains unclear.
We aimed to investigate the effect of surgical margin status on biochemical recurrence in pathologically organconfined prostate cancer.
Clinical and pathological data included age, prostate specific antigen, prostate volume, tumor volume, International Society of Urological Pathology (ISUP) grade group, lymphovascular invasion, perineural invasion, biochemical recurrence and surgical margin status. Followup schedules were developed by the surgeon in accordance with the European Association of Urology (EAU) prostate cancer guidelines. Biochemical recurrence was defined as PSA≥0.2 ng/ml.
Analysis of Surgical Specimens
Before macroscopic sampling, all specimens were left in
10% formalin for 18-24 hours. Afterward, the dimensions
of the specimens were recorded, and the specimen surfaces
were painted with ink. The entire material was sliced from
the apical (distal) to the basal (bladder neck) into 3 mm
thick sections and blocked for embedding in paraffin. Two
sections with 3-4 micron thickness were taken from the
blocks and examined under a microscope. All cases were
re-evaluated by one pathologist according to the 2014 ISUP modified Gleason grading system. While evaluating
surgical margins, contact of tumor cells with the dye in
the areas with surgical border staining was considered as
positive surgical margin (PSM) (Figure 1). A close surgical
margin (CSM) was reported when the tumor approached
the margin by less than 1 mm (Figure 2).
Figure 1: Tumor reaches the inked surgical margin (H&E, x200).
Figure 2: Tumor approaching to within 1 mm of the margin (H&E, x200).
Statistical Analysis
All statistical analyses were performed using the SPSS 22.0 (IBM SPSS Statistics, IBM Corporation, Chicago, IL) software for Windows. The compliance of the numeric variables with the normal distribution was assessed with the Kolmogorov-Smirnov test. Demographic and clinicopathologic features were compared between the three surgical margin groups using Kruskal-Wallis tests and One-Way Anova tests for continuous variables and Chi squared tests for categorical variables. Significant parameters in the Kruskal-Wallis test were compared in binary groups using the Mann-Whitney U test. The median (interquartile range, IQR) was used to define the non normally distributed variables, while frequency and percentage were used for categorical variables. In all the analyses, the statistical significance level was accepted as 0.05.
Table I: Patients demographic and clinicopathologic characteristics by surgical margin status
PSA values were found to be significantly higher in the patients with PSM compared to the patients with CSM (p=0.005). Tumor volume was statistically significantly higher in PSM and CSM groups compared to NSM (p=0.018 PSM vs NSM, p=0.007 CSM vs NSM). Furthermore, it was observed that the patients in the PSM and CSM groups had higher ISUP grade compared to the patients in the NSM group (p=0.004). After a median follow-up of 12.3 months, BCR occurred in 4 (19%), 5 (23.9%), and 12 (57.1%) patients with negative, close and positive surgical margins, respectively (Table II).
Table II: Recurrence rates with surgical margin status
In univariate analysis, we discovered a statistically significant relationship between preoperative PSA value (p<0.001), tumor volume (p=0.001), ISUP grade group 4-5 (p=0.027), PSM (p=0.017), CSM (p=0.006) and BCR. In multivariate analysis, a high preoperative PSA value (p<0.001) and PSM (p=0.021) were found to be statistically significant (Table III).
Biochemical recurrence may develop during follow-up in the patients who had organ-confined prostate cancer and underwent radical prostatectomy. In a recent study conducted by Stolzenbach et al., 5-year BCR-free survival rates in pathological organ-confined prostate cancer were reported to be approximately 88% [11]. Aoun et al. associated the BCR development in pT2 prostate cancer with factors such as insufficient diagnosis of surgical margin positivity, limited sections examined even though the entire specimen was sampled, PSA secretion of the postoperative residual benign prostate tissues and occult lymph node metastasis [12].
The presence of tumor closer than 1 mm to the painted surgical margin was accepted as CSM when defining the proximity to the surgical margin in this study. While determining this, we considered the existence of the publications accepting a value of 1 mm in the literature [13,14]. Whalen et al. have found that BCR developed more commonly in patients with close surgical margins than patients with negative surgical margins. They even stated that the patients with CSM showed similar rates of BCR development as the patients with PSM [13]. Similarly, Herforth et al. have shown that proximity to the surgical margin increased BCR. However, they emphasized that in the absence of high-risk parameters for BCR, surgical margin status alone did not increase metastasis, prostate cancer specific mortality and all-cause mortality, and that surgical margin status alone should not be used to decide adjuvant treatment [14]. In our study, contrary to these studies, we found that the presence of tumor close to the surgical margin did not affect BCR in organ-confined disease.
In some studies, the presence of a tumor closer than 0.1 mm to the surgical margin was accepted as close surgical margin. Lu et al. have found that the Gleason score and the presence of positive surgical margin were the strongest prognostic factors affecting BCR, and the presence of tumors close to the surgical margin led to the development of BCR [15]. In another study, Izard et al. have shown that the presence of tumors close to the surgical margin had a similar rate of BCR risk as in the patients with positive surgical margins. In these studies, the distance of 0.1 mm was measured by comparing it to either the visual field diameter or fibroblast size [16]. We think that the evaluation of this proximity according to the visual field diameter or the width of a few fibroblasts is subjective and will vary between pathologists. Moreover, prostatectomy materials are macroscopically sampled in approximately 3 mm thick pieces and then 3-4 micron sections are obtained and examined. The fact that the tumor is closer than 0.1 mm in these sections suggests that the surgical margin may be positive in the following sections as stated by Izard et al. in their study, and this situation remains uncertain since all tissues cannot be examined microscopically. For these reasons, we considered the presence of a tumor closer than 1 mm to the surgical margin as close surgical margin in our study.
EAU prostate cancer guidelines have emphasized that extraprostatic spread, seminal vesicle invasion and lymph node invasion may increase the risk of BCR [10]. In the literature, there are patients with these parameters in the study cohorts that indicate a relationship between the distance to the surgical margin and BCR. We believe that evaluating these parameters and proximity to the surgical margin together affects the research results. Therefore, we have excluded the patients with extraprostatic invasion, seminal vesicle invasion and lymph node positivity on pathology in the study group.
This study has some limitations to consider, including the retrospective design and shorter follow-up time compared to other studies. In addition, the relatively small number of the patients is seen as another limiting factor. The reason for this is that patients with organ-confined prostate cancer (pT2) were included in the study. Although this limits the number of patients, it makes our study more valuable. Moreover, the evaluation of all sections by the same pathologist eliminated an interobserver evaluation difference.
CONFLICT of INTEREST
The authors of this manuscript declare no conflict of
interest.
FUNDING
The authors state that this work has not received any
funding.
AUTHORSHIP CONTRIBUTIONS
Concept: AO, OK, Design: AO,RO, Data collection or
processing: AO, RO, MD, Analysis or Interpretation: AO,
RO, Literature search: AO, Writing: AO, OK, Approval:
AO, RO, MD, OK.
1) Boorjian SA, Karnes RJ, Crispen PL, Carlson RE, Rangel LJ,
Bergstralh EJ, Blute ML. The impact of positive surgical margins
on mortality following radical prostatectomy during the prostate
specific antigen era. J Urol. 2010;183:1003-9.
2) Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange
PH, Lin DW. Positive surgical margins at radical prostatectomy
predict prostate cancer specific mortality. J Urol. 2010;183:2213-8.
3) Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru
N, Slawin K, Scardino PT. Do margins matter? The prognostic
significance of positive surgical margins in radical prostatectomy
specimens. J Urol. 2008;179:S47-51.
4) Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker
PD, Klein E, Cangiano T, Schröder FH, Scardino PT, Kattan
MW. Prognostic impact of positive surgical margins in surgically
treated prostate cancer: Multi-institutional assessment of 5831
patients. Urology. 2005;66:1245-50.
5) Alkhateeb S, Alibhai S, Fleshner N, Finelli A, Jewett M, Zlotta
A, Nesbitt M, Lockwood G, Trachtenberg J. Impact of positive
surgical margins after radical prostatectomy differs by disease
risk group. J Urol. 2010;183:145-50.
6) Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM.
Biological determinants of cancer progression in men with
prostate cancer. JAMA. 1999;281:1395-400.
7) Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW,
Scardino PT. Cancer control with radical prostatectomy alone in
1,000 consecutive patients. J Urol. 2002;167:528-34.
8) Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ,
van Krieken JH. Circumferential margin involvement is still an
important predictor of local recurrence in rectal carcinoma: Not
one millimeter but two millimeters is the limit. Am J Surg Pathol.
2002;26:350-7.
9) Bernstein TE, Endreseth BH, Romundstad P, Wibe A.
Circumferential resection margin as a prognostic factor in rectal
cancer. Br J Surg. 2009;96:1348-57.
10) Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L,
Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati
N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M,
Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast
TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam
TB, Cornford P, Mottet N. Prognostic Value of Biochemical
Recurrence Following Treatment with Curative Intent for
Prostate Cancer: A Systematic Review. Eur Urol. 2019;75:967-87.
11) Stolzenbach LF, Knipper S, Mandel P, Ascalone L, Deuker M,
Tian Z, Heinzer H, Tilki D, Maurer T, Graefen M, Karakiewicz
PI, Steuber T. Oncological outcomes of pathologically organconfined,
lymph node-positive prostate cancer after radical
prostatectomy. Urol Oncol. 2021;39:234.e1-234.e7.
12) Aoun F, Albisinni S, Henriet B, Tombal B, Van Velthoven R,
Roumeguère T. Predictive factors associated with biochemical
recurrence following radical prostatectomy for pathological T2
prostate cancer with negative surgical margins. Scand J Urol.
2017;51:20-6.
13) Whalen MJ, Shapiro EY, Rothberg MB, Turk AT, Woldu SL, Roy
Choudhury A, Patel T, Badani KK. Close surgical margins after
radical prostatectomy mimic biochemical recurrence rates of
positive margins. Urol Oncol. 2015;33:494.e9-494.e14.
14) Herforth C, Stroup SP, Chen Z, Howard LE, Freedland SJ, Moreira
DM, Terris MK, Aronson WJ, Cooperberg MR, Amling CL,
Kane CJ. Radical prostatectomy and the effect of close surgical
margins: results from the Shared Equal Access Regional Cancer
Hospital (SEARCH) database. BJU Int. 2018;122:592-8.